Showing results (71-80 of 784) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|July 5, 2020
Cognitive disorders in people living with HIVAlan Winston, Serena Spudich
The Lancet. HIV|November 20, 2019
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
The Lancet. HIV|December 25, 2019
Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort studyKunjal Patel, Brad Karalius, Kathleen Powis, et al.
The Lancet. HIV|December 12, 2018
Issues about periconception use of dolutegravir are reminiscent of early concerns about efavirenzVivian Black, Sheree R Schwartz
The Lancet. HIV|December 2, 2019
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and useJohan Vekemans, William Snow, Patricia E Fast, et al.
The Lancet. HIV|February 17, 2020
The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling studyAdam Akullian, Michelle Morrison, Geoffrey P Garnett, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
The Lancet. HIV|January 9, 2020
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trialDirk Schürmann, Deanne Jackson Rudd, Saijuan Zhang, et al.
The Lancet. HIV|December 4, 2018
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case reportStephanie E Cohen, Darpun Sachdev, Sulggi A Lee, et al.
The Lancet. HIV|September 27, 2025
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept studyDeborah Persaud, Anne Coletti, Bryan S Nelson, et al.
Pageof 79